Long-term observations of a patient with choroidal melanoma following fractionated stereotactic radiotherapy: A case report.

A 60-year-old man with choroidal melanoma was treated with fractionated stereotactic radiotherapy and followed for 6 years. During this period, the tumor has not changed in size, and the patient has experienced only a slight decrease in visual acuity. In this case, stereotactic radiotherapy appears to have been safe and effective and may also be a cost-effective alternative to particle or plaque therapy. [ABSTRACT FROM AUTHOR]